>
Switch to:

Tekla Life Sciences Investors Additional Paid-In Capital

: $356.3 Mil(As of Sep. 2020)
View and export this data going back to . Start your Free Trial

Tekla Life Sciences Investors's quarterly additional paid-in capital stayed the same from Sep. 2019 ($0.0 Mil) to Mar. 2020 ($0.0 Mil) but then increased from Mar. 2020 ($0.0 Mil) to Sep. 2020 ($356.3 Mil).

Tekla Life Sciences Investors's annual additional paid-in capital stayed the same from Sep. 2018 ($0.0 Mil) to Sep. 2019 ($0.0 Mil) but then increased from Sep. 2019 ($0.0 Mil) to Sep. 2020 ($356.3 Mil).


Tekla Life Sciences Investors Additional Paid-In Capital Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Tekla Life Sciences Investors Annual Data
Sep17 Sep18 Sep19 Sep20
Additional Paid-In Capital 0.00 0.00 0.00 356.30

Tekla Life Sciences Investors Semi-Annual Data
Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20
Additional Paid-In Capital Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 356.30

Tekla Life Sciences Investors Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Tekla Life Sciences Investors Additional Paid-In Capital Related Terms


Tekla Life Sciences Investors Additional Paid-In Capital Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)